Virginia Administrative Code › Title 12 - HEALTH › Agency 5 - DEPARTMENT OF HEALTH › Chapter 90 - REGULATIONS FOR DISEASE REPORTING AND CONTROL › Part III - Reporting of Disease › Section 12VAC5-90-80 - Lists of diseases that shall be reported

Current through Register Vol. 40, No. 24, July 15, 2024
A. Reportable
				  disease list. The board declares suspected or confirmed cases of the following
				  named diseases, toxic effects, and conditions to be reportable by the persons
				  enumerated in
				  12VAC5-90-90. Conditions
				  identified by an asterisk (*) require immediate communication to the local
				  health department by the most rapid means available upon suspicion or
				  confirmation, as defined in subsection C of this section. Other conditions
				  should be reported within three days of suspected or confirmed diagnosis,
				  unless otherwise specified in this section. Neonatal Abstinence Syndrome shall
				  be reported as specified in subsection E of this section. Coronavirus disease
				  2019 (SARS-CoV-2) shall be reported as specified in subsection I of the
				  section.
Amebiasis (Entamoeba histolytica)
*Anthrax (Bacillus anthracis)
Arboviral infections (e.g., CHIK, dengue, EEE, LAC, SLE,
					 WNV, Zika)
Babesiosis (Babesia spp.)
*Botulism (Clostridium botulinum)
*Brucellosis (Brucella spp.)
Campylobacteriosis (Campylobacter spp.)
Candida auris, infection or colonization
Carbapenemase-producing organism, infection or
					 colonization
Chancroid (Haemophilus ducreyi)
Chickenpox (Varicella virus)
Chlamydia trachomatis infection
*Cholera (Vibrio cholerae O1 or O139)
*Coronavirus infection, severe (e.g., SARS-CoV,
					 MERS-CoV)
Coronavirus disease 2019 (COVID-19 or SARS-CoV-2)
Cryptosporidiosis (Cryptosporidium spp.)
Cyclosporiasis (Cyclospora spp.)
*Diphtheria (Corynebacterium diphtheriae)
*Disease caused by an agent that may have been used as a
					 weapon
Ehrlichiosis/Anaplasmosis (Ehrlichia spp., Anaplasma
					 phagocytophilum)
Giardiasis (Giardia spp.)
Gonorrhea (Neisseria gonorrhoeae)
Granuloma inguinale (Calymmatobacterium
					 granulomatis)
*Haemophilus influenzae infection, invasive
Hantavirus pulmonary syndrome
Hemolytic uremic syndrome (HUS)
*Hepatitis A
Hepatitis B (acute and chronic)
Hepatitis C (acute and chronic)
Hepatitis, other acute viral
Human immunodeficiency virus (HIV) infection
Influenza, confirmed
*Influenza-associated deaths if younger than 18 years of
					 age
Lead, blood levels
Legionellosis (Legionella spp.)
Leprosy (Hansen's disease) (Mycobacterium leprae)
Leptospirosis (Leptospira interrogans)
Listeriosis (Listeria monocytogenes)
Lyme disease (Borrelia spp.)
Lymphogranuloma venereum (Chlamydia trachomatis)
Malaria (Plasmodium spp.)
*Measles (Rubeola)
*Meningococcal disease (Neisseria meningitidis)
Mumps
Neonatal abstinence syndrome (NAS)
Ophthalmia neonatorum
*Outbreaks, all (including foodborne, health
					 care-associated, occupational, toxic substance-related, waterborne, and any
					 other outbreak)
*Pertussis (Bordetella pertussis)
*Plague (Yersinia pestis)
*Poliovirus infection, including poliomyelitis
*Psittacosis (Chlamydophila psittaci)
*Q fever (Coxiella burnetii)
*Rabies, human and animal
Rabies treatment, post-exposure
*Rubella, including congenital rubella syndrome
Salmonellosis (Salmonella spp.)
Shiga toxin-producing Escherichia coli infection
Shigellosis (Shigella spp.)
*Smallpox (Variola virus)
Spotted fever rickettsiosis (Rickettsia spp.)
Streptococcal disease, Group A, invasive or toxic
					 shock
Streptococcus pneumoniae infection, invasive if younger
					 than five years of age
Syphilis (Treponema pallidum) report *congenital, *primary,
					 *secondary, and other
Tetanus (Clostridium tetani)
Toxic substance-related illness
Trichinosis (Trichinellosis) (Trichinella spiralis)
*Tuberculosis, active disease (Mycobacterium tuberculosis
					 complex)
Tuberculosis infection
*Tularemia (Francisella tularensis)
*Typhoid/Paratyphoid infection (Salmonella Typhi,
					 Salmonella Paratyphi)
*Unusual occurrence of disease of public health
					 concern
*Vaccinia, disease or adverse event
Vancomycin-intermediate or vancomycin-resistant
					 Staphylococcus aureus infection
*Vibriosis (Vibrio spp.)
*Viral hemorrhagic fever
*Yellow fever
Yersiniosis (Yersinia spp.)
B. Conditions reportable by directors of
				  laboratories. Laboratories shall report all test results indicative of and
				  specific for the diseases, infections, microorganisms, conditions, and toxic
				  effects specified in this subsection for humans. Such tests include
				  microbiological culture, isolation, or identification; assays for specific
				  antibodies; and identification of specific antigens, toxins, or nucleic acid
				  sequences. Additional condition-specific requirements are noted in this
				  subsection and subsection D of this section. Conditions identified by an
				  asterisk (*) require immediate communication to the local health department by
				  the most rapid means available upon suspicion or confirmation, as defined in
				  subsection C of this section. Other conditions should be reported within three
				  days of suspected or confirmed diagnosis.
Amebiasis (Entamoeba histolytica)
*Anthrax (Bacillus anthracis)
Arboviral infection, for example, CHIK, dengue, EEE, LAC,
					 SLE, WNV, or Zika
Babesiosis (Babesia spp.)
*Botulism (Clostridium botulinum)
*Brucellosis (Brucella spp.)
Campylobacteriosis (Campylobacter spp.)
Candida auris - Include available antimicrobial
					 susceptibility findings in report.
Carbapenemase-producing organism - Include available
					 antimicrobial susceptibility findings in report.
Chancroid (Haemophilus ducreyi)
Chickenpox (Varicella virus)
Chlamydia trachomatis infection
*Cholera (Vibrio cholerae O1 or O139)
*Coronavirus infection, severe (e.g., SARS-CoV,
					 MERS-CoV)
Coronavirus disease 2019 (COVID-19 or SARS-CoV-2)
Cryptosporidiosis (Cryptosporidium spp.)
Cyclosporiasis (Cyclospora spp.)
*Diphtheria (Corynebacterium diphtheriae)
Ehrlichiosis/Anaplasmosis (Ehrlichia spp., Anaplasma
					 phagocytophilum)
Giardiasis (Giardia spp.)
Gonorrhea (Neisseria gonorrhoeae) - Include available
					 antimicrobial susceptibility findings in report.
*Haemophilus influenzae infection, invasive
Hantavirus pulmonary syndrome
*Hepatitis A
Hepatitis B (acute and chronic) - For All hepatitis B
					 patients, also report available results of serum alanine aminotransferase (ALT)
					 and all available results from the hepatitis panel.
Hepatitis C (acute and chronic) - For all patients with any
					 positive HCV test, also report all results of HCV viral load tests, including
					 undetectable viral loads and report available results of serum alanine
					 aminotransferase (ALT) and all available results from the hepatitis
					 panel.
Hepatitis, other acute viral - Any finding indicative of
					 acute infection with hepatitis D, E, or other cause of viral hepatitis. For any
					 reportable hepatitis finding, submit all available results from the hepatitis
					 panel.
Human immunodeficiency virus (HIV) infection - For
					 HIV-infected patients, report all results of CD4 and HIV viral load tests,
					 including undetectable viral loads. For HIV-infected patients, report all HIV
					 genetic nucleotide sequence data associated with HIV drug resistance tests by
					 electronic submission. For children younger than three years of age, report all
					 tests regardless of the test findings (e.g., negative or positive).
Influenza, confirmed - By culture, antigen detection by
					 direct fluorescent antibody (DFA), or nucleic acid detection.
Lead, blood levels - All lead results from tests of venous
					 or capillary blood performed by a laboratory certified by the Centers for
					 Medicare and Medicaid Services in accordance with
					 42 USC §
												263a, the Clinical Laboratory Improvement
					 Amendment of 1988 (CLIA-certified).
Legionellosis (Legionella spp.)
Leptospirosis (Leptospira interrogans)
Listeriosis (Listeria monocytogenes), invasive or if
					 associated with miscarriage or stillbirth from placental or fetal tissue
Lyme disease (Borrelia spp.)
Malaria (Plasmodium spp.)
*Measles (Rubeola)
*Meningococcal disease (Neisseria meningitidis), invasive -
					 Include identification of gram-negative diplococci.
Mumps
*Mycobacterial diseases - (See
					 12VAC5-90-225 B) Report any of the
					 following:
1. Acid fast
				  bacilli;
2. M. tuberculosis complex
				  or any other mycobacteria;
3.
				  Antimicrobial susceptibility results for M. tuberculosis complex.
*Pertussis (Bordetella pertussis)
*Plague (Yersinia pestis)
*Poliovirus infection
*Psittacosis (Chlamydophila psittaci)
*Q fever (Coxiella burnetii)
*Rabies, human and animal
*Rubella
Salmonellosis (Salmonella spp.)
Shiga toxin-producing Escherichia coli infection
Shigellosis (Shigella spp.)
*Smallpox (Variola virus)
Spotted fever rickettsiosis (Rickettsia spp.)
Streptococcal disease, Group A, invasive or toxic
					 shock
Streptococcus pneumoniae infection, invasive if younger
					 than five years of age
*Syphilis (Treponema pallidum)
Toxic substance-related illness - By blood or urine
					 laboratory findings above the normal range, including heavy metals, pesticides,
					 and industrial-type solvents and gases. When applicable and available, report
					 speciation of metals when blood or urine levels are elevated in order to
					 differentiate the chemical species (elemental, organic, or inorganic).
Trichinosis (Trichinellosis) (Trichinella spiralis)
Tuberculosis infection
*Tularemia (Francisella tularensis)
*Typhoid/Paratyphoid infection (Salmonella Typhi,
					 Salmonella Paratyphi A, Salmonella Paratyphi B, Salmonella Paratyphi C)
*Vaccinia, disease or adverse event
Vancomycin-intermediate or vancomycin-resistant
					 Staphylococcus aureus infection - Include available antimicrobial
					 susceptibility findings in report.
*Vibriosis (Vibrio spp., Photobacterium damselae, Grimontia
					 hollisae), other than toxigenic Vibrio cholera O1 or O139, which are reportable
					 as cholera
*Viral hemorrhagic fever
*Yellow fever
Yersiniosis (Yersinia spp.)